BDTX
USDBlack Diamond Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.850
High
$3.860
Low
$3.620
Volume
0.96M
Company Fundamentals
Market Cap
206.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.92M
Exchange
NMS
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $10
HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and lowers the price target from $12 to $10.
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025Exploring partnership opportunities to advance
Related Stocks
AMH
American Homes 4 Rent Common Shares of Beneficial Interest
RILYP
B. Riley Financial Inc. Depositary Shares each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred Stock
DMAC
DiaMedica Therapeutics Inc.
HD
Home Depot Inc. (The)
SYK
Stryker Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.